Cite
HARVARD Citation
Zhang, X. et al. (2018). Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?. Hepatology. 68 (2), p. 786. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zhang, X. et al. (2018). Is Sorafenib an Optimal Treatment for Hepatocellular Carcinoma With Macrovascular Invasion or Metastatic Disease?. Hepatology. 68 (2), p. 786. [Online].